The FDA pulls key DEI initiative for cancer studies from its website
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
The Mirror US on MSN7h
Parkinson's disease could be treated by FDA-approved cancer drug after major research breakthrough
A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...
Morningstar6d
Daiichi Sankyo Shares Jump After U.S. FDA Approves Breast Cancer Drug
The Japanese government approved the breast cancer drug in late December. Jefferies analysts said in a note that they had assumed a 65% chance of FDA approval, but they believe that the market was ...
Healio5d
FDA approves Datroway for advanced breast cancer
The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer. The agent improved ... is a Trop-2-directed antibody-drug conjugate.
Labroots6d
FDA approval of new drug for hormone positive breast cancer
On January 17, 2025, the Food and Drug Administration (FDA ... This approval marks a significant advancement in the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor ...
MedCity News6d
AstraZeneca, Daiichi Sankyo ADC Lands FDA Approval in Advanced Breast Cancer
The company is also seeking to expand use of the drug to other cancers. Last week, the FDA accepted an application seeking approval of the ADC for EGFR-mutated non-small cell lung cancer.
pharmaphorum2d
ImmunoGen ELAHERE wins accelerated FDA approval for ovarian cancer
ImmunoGen, Inc. has announced that its platinum-resistant ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) has been granted FDA accelerated approval. This first FDA antibody-drug ...
Renal & Urology News4d
FDA Approves Marketing of Nicotine Pouches
Approval marks first time the agency has approved sale of a nicotine pouch. (HealthDay News) — Following an extensive scientific review, the US Food and Drug Administration has authorized the ...
JD Supra1d
FDA Bans Red Dye No. 3 Under the Delaney Clause
The US Food and Drug Administration (FDA) has revoked its authorization for the use of FD&C Red No. 3, also known as Red Dye No. 3. Issued on ...
ThePrint on MSN6d
2nd ‘living drug’ against blood cancer gets regulatory nod. All about Qartemi, made in India
Therapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...
JD Supra6d
Drugs and Biologics at FDA: Reflections on 2024 Activity Shed Light on the Road Ahead
For such appointed positions (e.g., FDA Commissioner), until a position is formally and “permanently” filled by the appointment (and as applicable the Senate confirmation) process, roles may ...